http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109554364-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-10 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2018-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109554364-B |
| titleOfInvention | TSNAX gene inhibitor and application thereof in tumors |
| abstract | The invention belongs to the field of biological medicine, and particularly relates to a TSNAX gene inhibitor and application thereof in tumors. The gene sequence of the target inhibitor of the TSNAX gene is 5'-GGTTTCTAAGAAGCTGTATAC-3' (SEQ ID No. 1), or a DNA sequence which has 90 percent of homology with the DNA sequence shown in SEQ ID No.1 and has the same or similar functions. The TSNAX gene inhibitor is used for preparing an anti-tumor medicament, and the tumor is brain glioma. By applying the inhibitor in glioma, the inhibitor can inhibit the migration and invasion of glioma cells, induce the apoptosis of glioma cells, and has the advantages of preventing and improving the treatment effect of glioma in a targeted manner. |
| priorityDate | 2018-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 202.